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Introduction: The intra-aortic balloon pump is routinely used in cardiac surgery; however, its impact on outcome
is still a matter of debate and several randomized trials have been published recently. We perform an updated
meta-analysis of randomized controlled trials that investigated the use of preoperative intra-aortic balloon pump
in adult patients undergoing coronary artery bypass grafting.
Methods: Potentially eligible trials were identified by searching the Medline, Embase, Scopus, ISI Web of
Knowledge and The Cochrane Library. Searches were not restricted by language or publication status and were
updated in August 2014. Randomized controlled trials on preoperative intra-aortic balloon pump in patients
undergoing coronary artery bypass grafting either with or without cardiopulmonary bypass were identified. The primary
end point was mortality at the longest follow-up available and the secondary end point was 30-day mortality.
Results: The eight included randomized clinical trials enrolled 625 patients (312 to the intra-aortic balloon pump group
and 313 to control). The use of intra-aortic balloon pump was associated with a significant reduction in the risk of mortality
(11 of 312 (3.5%) versus 33 of 313 (11%), risk ratio = 0.38 (0.20 to 0.73), P for effect = 0.004, P for heterogeneity = 0.7,
I-square = 0%, with eight studies included). The benefit on mortality reduction was confirmed restricting the analysis to
trials with low risk of bias, to those reporting 30-day follow-up and to patients undergoing coronary artery bypass graft
surgery with cardiopulmonary bypass.
Conclusions: Preoperative intra-aortic balloon pump reduces perioperative and 30-day mortality in high-risk patients
undergoing elective coronary artery bypass grafting.Introduction
The intra-aortic balloon pump is used in different
clinical conditions where myocardial function is dimin-
ished, even if its effect on outcome is debated; indeed, it
does not improve 30-day and one-year survival in
patients with acute coronary syndrome complicated by
cardiogenic shock undergoing revascularization [1,2].
Its beneficial physiological effects are well recognized:
the intra-aortic balloon pump acts by increasing diastolic
blood pressure [3,4] and improving diastolic coronary* Correspondence: landoni.giovanni@hsr.it
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unless otherwise stated.perfusion. Furthermore, it increases cardiac output and
stroke volume by reducing afterload. The ability to act
on diastolic pressure has a great importance in clinical
practice since the augmented diastolic pressure results
in a redistribution of coronary blood flow toward ische-
mic areas of the myocardium [5,6].
The perioperative use of intra-aortic balloon pump in
cardiac surgery is widespread and supported by a large
amount of data [7,8]. Indeed, intra-aortic balloon pump
use is among the few topics with a documented im-
provement in survival according to randomized evidence
as summarized in a recent international consensus con-
ference [9].
A recent randomized trial on intra-aortic balloon
pump use in coronary artery bypass graft surgery was
underpowered to confirm the beneficial effects of intra-al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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patients undergoing nonemergent coronary operations,
with a stable hemodynamic profile and a left ventricular
ejection fraction less than 35%, the preincision (after
anesthesia induction and before skin incision) insertion
of intra-aortic balloon pump did not result in a better
outcome [10].
We therefore decided to perform an updated meta-
analysis of randomized trials studying the effect of pre-
operative intra-aortic balloon pump use in coronary
artery bypass graft surgery to address the effect of this
therapy on survival.Materials and methods
We performed a systematic review and meta-analysis of
randomized trials in accordance with the Preferred Report-
ing Items for Systematic reviews and Meta-Analyses
(PRISMA) guidelines.Data sources and study selection
We searched for all randomized controlled trials, of any
size or length of follow-up that reported the use of pre-
operative (before surgery) intra-aortic balloon pump in
adult high-risk patients undergoing cardiac surgery. We
defined as high risk the patients with at least one among:
left ventricular ejection fraction <40%, left main coron-
ary artery stenosis equal or more than 70%, reoperation,
unstable angina despite medical treatment, recent acute
myocardial infarction, or left ventricular hypertrophy in
patients with coronary artery disease undergoing coron-
ary artery bypass graft. Potentially eligible trials were
identified by searching the Medline, Embase, Scopus, ISI
Web of Knowledge and The Cochrane Library (updated
1 August 2014) using a combination of subject headings
and text words to identify randomized controlled trials
of preoperative intra-aortic balloon pump use. The full
Medline search strategies aimed to include any random-
ized controlled trials ever performed on humans using
preoperative intra-aortic balloon pump in any cardiac
surgery is presented in Additional file 1. Searches were
not restricted by language or publication status. We also
examined the reference lists of eligible trials and reviews
together with the abstracts of international congresses.
We excluded duplicate publications, studies without
mortality data, abstracts older than three years (those
that did not reach the full peer review publication status)
and those comparing different timing of intra-aortic bal-
loon pump positioning (for example all patients were
assigned to receive an intra-aortic balloon pump before
or after surgery). Two authors independently screened
the search output to identify records of potentially eli-
gible trials, the full texts of which were retrieved and
assessed for inclusion.Outcome data
The primary end point for the present meta-analysis was
mortality at the longest follow-up as reported by authors
(up to three months in these trials) and the secondary
end point was 30-day mortality.
Data extraction and risk of bias assessment
We extracted data on setting, outcome and length of
follow-up. If a trial reported multiple comparisons, the
comparators were either aggregated as a single group or
excluded depending on the type of treatment and the
specific analysis performed. We assessed the risk of bias
associated with the method of sequence generation, allo-
cation concealment, blinding, and the completeness of
outcome data. We rated the risk of bias as being low,
unclear, or high according to established criteria.
Statistical analysis
To analyze the binary outcome we calculated the natural
logarithms of risk ratios and its standard deviation. We
pooled these using the inverse variance method and a
fixed effect model [11]. To assess heterogeneity in re-
sults of individual studies, we used Cochran’s Q statistic
and the I-square statistic (I-square >25% was used as a
threshold indicating significant heterogeneity). Publica-
tion bias was assessed by visually inspecting funnel plots
of the primary outcome, by analytical appraisal based on
the Begg adjusted-rank correlation test and on Egger’s
linear regression test (a two-sided P value of 0.10 or less
was regarded as significant).
Sensitivity analyses were done to quantify the effect of
intra-aortic balloon pump when restricted to trials with
low risk of bias, to trials that report the 30-day mortal-
ity, and divided by on- and off-pump setting. We also in-
vestigated the influence of a single study on the overall
risk estimate by sequentially removing a study to test the
robustness of the main results.
Statistical significance was set at the two-tailed 0.05 level
for hypothesis testing. Data analysis was performed using
STATA 11.0 Software (StataCorp LP, College Station,
TX, USA).
Results
Characteristics of the included individual studies
Out of 238 publications we selected eight randomized
trials [10,12-18] meeting the inclusion/exclusion criteria
(Figure 1) while another eight manuscripts were consid-
ered major exclusions [1,19-24] because all patients had
received intra-aortic balloon pump support [19,20,24],
the trial was not performed only in a cardiac surgery
setting [1], the abstract was published before 2011 [23],
the intra-aortic balloon pump was inserted postoperatively
[22] and because of overlapping population [21,2].
Figure 1 Flow diagram for selection of articles.
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to the intra-aortic balloon pump group and 313 to the
control group). Table 1 shows the clinical data on setting,
type of comparator, outcome data and length of follow-up.
Study quality appraisal indicated that the eight included
studies were of variable quality (Table S1 in Additional file
1) and that only four of them had a low risk of bias.
Quantitative data synthesis
The principal analysis (Figure 2) showed that the use of
intra-aortic balloon pump was associated with a signifi-
cant reduction in the risk of overall mortality (11 of 312
(3.5%) in the intra-aortic balloon pump group versus 33
of 313 (11%) in the control group, risk ratio = 0.38 (0.20
to 0.73), P for effect = 0.004, P for heterogeneity = 0.7, I-
square = 0%, with eight studies included). Visual inspec-
tion of funnel plots did not identify a skewed or asym-
metrical shape (Figure 3) and quantitative evaluation did
not suggest a presence of publication bias, as measured
by Egger test (P = 0.6) and Begg test (P = 0.5). Sensitivity
analyses considering only data from the four studies with
low risk of bias (Figure 4) confirmed the reduction in
the risk of mortality (7 of 141 (5.0%) in the intra-aortic
balloon pump group versus 23 of 129 (18%) in the con-
trol group, risk ratio = 0.31, (0.14 to 0.70), P for effect =
0.005, P for heterogeneity = 0.7, I-square = 0%, with four
studies included). The overall result was also confirmed
restricting the analysis to trials that reported the 30-day
mortality (Figure 5) (11 of 254 (4.3%) in the intra-aortic
balloon pump group versus 25 of 260 (9.6%) in the con-
trol group, risk ratio = 0.42 (0.21 to 0.86), P for effect =
0.02, P for heterogeneity = 0.6, I-square = 0%, with sixstudies included) and in surgeries performed with car-
diopulmonary bypass (9 of 190 (4.7%) in the intra-aortic
balloon pump group versus 27 of 173 (16%) in the con-
trol group, risk ratio = 0.36 (0.17 to 0.74), P for effect =
0.01, P for heterogeneity = 0.5, I-square = 0%, with six
studies included) (Additional file 2: Figure S1).
Moreover, sensitivity analyses performed by removing
each single study from the meta-analysis to determine
the influence of individual data sets to the pooled risk
ratios (Additional file 3: Figure S2), did not determine
major changes in direction or magnitude of statistical
findings, confirming for each analysis the pooled effect
(risk ratio <1) and the statistical significance (P <0.05).
Discussion
The most important finding of this meta-analysis is that
preoperative insertion of intra-aortic balloon pump re-
duces mortality in elective high-risk coronary artery by-
pass graft patients. This finding was already suggested
by previous meta-analyses [7,8,25] but they were chal-
lenged by a recent large randomized controlled trial that
concluded that the intra-aortic balloon pump was not
useful in this context even if it showed a trend toward
improved clinically relevant outcomes (major morbidity:
22 (40%) in the intra-aortic balloon pump group versus
17 (31%) in the control group, odds ratio =1.49 (0.68 to
3.33), P = 0.3, operative mortality: 4 (7.3%) in the intra-
aortic balloon pump group versus 8 (14%) in the control
group, odds ratio = 0.46 (0.13 to 1.43), P = 0.2).
When compared with other meta-analyses our work
includes three recent articles for a total of 402 new pa-
tients. We also included sensitivity analyses, almost
Table 1 Description of the eight randomized studies included in the meta-analysis








2013 Crit Care Med CABG After anesthesia
induction and
before skin incision
7/55 4 in IABP
group





CABG 16 to 18 hours before
surgery (in the ICU)
Not
reported
Not reported 30 30 30 days
Shi et al. [16] 2011 J Int Med Res OPCABG 1 hour before surgery Not
reported




2003 J Card Surg REDO-OPCABG After anesthesia
induction and before
skin incision
7/15 0 15 15 2 months
Christenson
et al. [13]





surgery (in the ICU)
3 in crossovers
−12 hours before




1997 Ann Thorac Surg REDO-CABG Before anesthesia
induction in theatre
(4 patients had insertion
in the ICU before
transfer to the
operating room)
9/24 1 in IABP
group




1997 Eur J Cardiothorac Surg CABG 2 different groups 11/20 0 32 20 Hospital
stay
−24 hours before
surgery (in the ICU)
− preoperatively in
the operating room,








Not reported 19 14 3 months
Crossover: number of patients assigned to the no-IABP group who received postoperative IABP insertion because of low cardiac output syndrome. CABG: coronary
artery bypass graft surgery; ICU: intensive care unit; OPCABG: off-pump coronary artery bypass graft surgery; IABP: intra-aortic balloon pump; REDO: a patient who
had already undergone sternotomy for cardiac surgery once in the past.
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meta-analyses and, most importantly, our meta-analysis
includes articles from four different research groups
from four different countries.
The role of the intra-aortic balloon pump has been re-
cently challenged by Thiele’s study [1] that showed no
difference in short- and long-term survival in patients
randomized to intra-aortic balloon pump versus standard
treatment (risk ratio = 2.60 (0.95 to 7.10), P = 0.05), recur-
rent revascularization (risk ratio = 0.91 (0.58 to 1.41),
P = 0.77), or stroke (risk ratio = 1.50 (0.25 to 8.84), P = 1.00)
in acute coronary syndrome complicated by cardiogenic
shock and planned for revascularization. It should be noted
that that study is not included in this meta-analysis because
only six patients underwent surgical revascularization.
The intra-aortic balloon pump acts by increasing dia-
stolic blood pressure [3], directly improving diastolic
coronary perfusion and increasing cardiac output andstroke volume by reducing afterload. The ability to act
on diastolic pressure has a great importance in clinical
practice because previous studies have demonstrated
that the augmented diastolic pressure results in a redis-
tribution of coronary blood flow toward ischemic areas
of the myocardium [5,6].
The value of some trials is to be questioned in the
light of the unacceptably high rate of intra-aortic balloon
pump-related complications [26,27]. The most recent
trial [10] reported two patients in the intra-aortic bal-
loon pump study group who did not receive the balloon
due to technical difficulties and four patients suffering
from vascular complications (12%). Strikingly, both in
the surgical [10] and nonsurgical [2] population of previ-
ously published studies there was a systematic need for
crossover from the control group to the intra-aortic
balloon pump group (approximately 13 to 17%), which
assumes a reproducible methodological bias.
Figure 2 Forest plot for the risk of overall mortality. RR: relative risk; CI: confidence interval.
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The main limitation of the present meta-analysis is that
four out of the eight included randomized controlled tri-
als were of suboptimal quality (but the results were con-
firmed when analyzing only the trials with low risk ofFigure 3 Funnel plot for the risk of mortality. LnRR: natural logarithm o
risk ratio.bias). Furthermore, traditional limitations of meta-
analyses due to variations in the treatment regimens, in
populations or major subgroups within trials, and in the
conduct of the trials apply to this study [28,29]. The
possibility of the beneficial effect of intra-aortic balloonf the risk ratio; selnRR: standard error of the natural logarithm of the
Figure 4 Forest plot for the risk of mortality in low risk of bias trials. IABP: intra-aortic balloon pump; RR: risk ratio; CI: confidence interval.
Figure 5 Forest plot for the risk of 30-day mortality. IABP: intra-aortic balloon pump; RR: risk ratio; CI: confidence interval.
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Zangrillo et al. Critical Care  (2015) 19:10 Page 7 of 8pump in non-isolated coronary operations is still to be
investigated since worldwide there is an increased per-
centage of associated procedures and some trials [10] do
not specify this surgical data.
Conclusions
Prophylactic intra-aortic balloon pump use reduces
perioperative mortality in high-risk patients undergoing
cardiac surgery according to the most updated evidence-
based medicine.
Key messages
 Intra-aortic balloon pump is used in different
clinical conditions where myocardial function is
diminished.
 Intra-aortic balloon pump acts by increasing
diastolic blood pressure with consequent
redistribution of coronary blood flow toward
ischemic areas of the myocardium.
 Intra-aortic balloon pump increases cardiac output
and stroke volume by reducing afterload.
 Recent evidence challenges the use of intra-aortic
balloon pump after myocardial infarction.
 Preoperative insertion of intra-aortic balloon pump
reduces mortality in elective high-risk coronary
artery bypass graft patients.
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